Related Experiment Videos
Clinical manifestations of onychomycosis
1Diseases of the Skin and Skin Cancer, Miami Beach, Florida.
Clinical and Experimental Dermatology
|September 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Finger and toenail onycholysis.
Journal of the European Academy of Dermatology and Venereology : JEADV·2014
HYPONYCHIUM ABNORMALITIES Congenital Aberrant Hyponychium vs. Acquired Pterygium Inversum Unguis vs. Acquired Reversible Extended Hyponychium: a proposed classification based on origin, pathology and outcome.
Journal of the European Academy of Dermatology and Venereology : JEADV·2014
Opportunistic toenail onychomycosis. The fungal colonization of an available nail unit space by non-dermatophytes is produced by the trauma of the closed shoe by an asymmetric gait or other trauma. A plausible theory.
Journal of the European Academy of Dermatology and Venereology : JEADV·2014
Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial.
Journal of the American Academy of Dermatology·1997
A multicenter, placebo-controlled, double-blind study of intermittent therapy with itraconazole for the treatment of onychomycosis of the fingernail.
Journal of the American Academy of Dermatology·1997
Global Guidelines in Dermatology Mapping Project (GUIDEMAP): a systematic review of scabies clinical practice guidelines.
Clinical and experimental dermatology·2026
Folliculitis decalvans in two families.
Clinical and experimental dermatology·2026
Topology and Quality of Life of Cutaneous T-Cell-Lymphomas: A Cross-sectional Study of 153 Patients.
Clinical and experimental dermatology·2026
Extramammary Paget Disease: A Review.
Clinical and experimental dermatology·2026
TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.
The Journal of experimental medicine·2026
Activation of PP2A-B56a leads to aberrant EGFR signaling and proliferative phenotypes in PDAC.
Molecular cancer therapeutics·2026
Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset.
Clinical pharmacology and therapeutics·2026
Payload-Free [89Zr]Zr-DFO*-sq-Enfortumab ImmunoPET for Imaging Nectin-4 Expression in Bladder Cancer.
Molecular pharmaceutics·2026